New therapies and better diagnostics are transforming lung cancer treatment in Poland

New screening methods, additional reimbursed therapies and more precise molecular diagnostics are transforming lung cancer treatment in Poland. The focus is on catching the disease earlier, as lung cancer remains one of the most common malignancies. Advances in imaging diagnostics and targeted therapies are improving patient outcomes, according to specialists.